Literature DB >> 26629218

Artificial pleural effusion in percutaneous microwave ablation of hepatic tumors near the diaphragm under the guidance of ultrasound.

Gang Wang1, Yao Sun2, Lin Cong2, Xuehong Jing2, Jing Yu2.   

Abstract

OBJECTIVE: To evaluate the feasibility, safety and efficacy of artificial pleural effusion in percutaneous microwave ablation of hepatic tumors near the diaphragm under ultrasound guidance.
METHODS: For localization and navigation of tumors near the dome of the diaphragm by ultrasound during microwave ablation in 14 tumors of 11 cases, artificial pleural effusion was performed in the volume of 1000~1500 ml of Normal saline or 5% Glucose injection solution via the right thoracic cavity. The tumor marker, AFP was monitored before and after operation in 6 times in a period of 2 years. We analyzed the successful rate and effectiveness of artificial pleural effusion.
RESULTS: The successful rate of artificial pleural effusion was 100% without complications. Artificial hydrothorax on the right eliminated the interference of intrapulmonary gas to the visualization of hepatic tumors near the diaphragm on ultrasound. In the follow-up of 2 years, the ablation rate reached to 92.9% with no serious complications. The AFP value before operation was in significant statistical difference with the others after operation (P = 0.000).
CONCLUSIONS: Artificial pleural effusion aids the visualization of hepatic tumors near the diaphragm on ultrasound. A good therapeutic effectiveness can be reached in percutaneous microwave ablation of tumors in the hepatic dome under the guidance of ultrasound.

Entities:  

Keywords:  Artificial pleural effusion; guidance; hepatic tumors; microwave ablation; ultrasound

Year:  2015        PMID: 26629218      PMCID: PMC4659106     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

1.  Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.

Authors:  Hitoshi Maruyama; Masanori Takahashi; Hiroyuki Ishibashi; Hidehiro Okugawa; Shinichiro Okabe; Masaharu Yoshikawa; Osamu Yokosuka
Journal:  Liver Int       Date:  2008-09-18       Impact factor: 5.828

2.  Intrapleural fluid infusion for MR-guided high-intensity focused ultrasound ablation in the liver dome.

Authors:  Joost W Wijlemans; Martijn de Greef; Gerald Schubert; Chrit T W Moonen; Maurice A A J van den Bosch; Mario Ries
Journal:  Acad Radiol       Date:  2014-08-07       Impact factor: 3.173

3.  High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience.

Authors:  Kelvin K C Ng; Ronnie T P Poon; See Ching Chan; Kenneth S H Chok; Tan To Cheung; Helen Tung; Ferdinand Chu; Wai Kuen Tso; Wan Ching Yu; Chung Mau Lo; Sheung Tat Fan
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

4.  Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session.

Authors:  Min Woo Lee; Hyo K Lim; Young Jun Kim; Dongil Choi; Young-Sun Kim; Won Jae Lee; Dong Ik Cha; Min Jung Park; Hyunchul Rhim
Journal:  J Ultrasound Med       Date:  2011-05       Impact factor: 2.153

5.  Microwave ablation for hepatic malignancies: a multiinstitutional analysis.

Authors:  Ryan T Groeschl; Charles H C Pilgrim; Erin M Hanna; Kerri A Simo; Ryan Z Swan; David Sindram; John B Martinie; David A Iannitti; Mark Bloomston; Carl Schmidt; Hooman Khabiri; Lawrence A Shirley; Robert C G Martin; Susan Tsai; Kiran K Turaga; Kathleen K Christians; William S Rilling; T Clark Gamblin
Journal:  Ann Surg       Date:  2014-06       Impact factor: 12.969

6.  Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm.

Authors:  Masahiko Koda; Masaru Ueki; Yoshiko Maeda; Ken-ichi Mimura; Kinya Okamoto; Yoshiko Matsunaga; Manri Kawakami; Keiko Hosho; Yoshikazu Murawaki
Journal:  AJR Am J Roentgenol       Date:  2004-09       Impact factor: 3.959

7.  The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study.

Authors:  Dezhi Zhang; Ping Liang; Xiaoling Yu; Zhigang Cheng; Zhiyu Han; Jie Yu; Fangyi Liu
Journal:  Int J Hyperthermia       Date:  2013-11       Impact factor: 3.914

Review 8.  Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites.

Authors:  Hyunchul Rhim; Hyo K Lim
Journal:  Abdom Imaging       Date:  2009 May-Jun

9.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.

Authors:  Inyoung Song; Hyunchul Rhim; Hyo K Lim; Young-Sun Kim; Dongil Choi
Journal:  Eur Radiol       Date:  2009-06-26       Impact factor: 5.315

View more
  2 in total

1.  Cone beam computed tomography-guided microwave ablation for hepatocellular carcinoma under the hepatic dome: a retrospective case-control study.

Authors:  Yiming Liu; Kunpeng Wu; Kaihao Xu; Chuan Tian; Dechao Jiao; Xinwei Han
Journal:  Quant Imaging Med Surg       Date:  2022-10

2.  Perfluorobutane contrast-enhanced ultrasonography: a new standard for ultrasonography-guided thermal ablation of sonographically occult liver tumours?

Authors:  Haiyuan Shi; Yi-Ting Ong; Apoorva Gogna; Nanda Venkatanarasimha; Sarat Kumar Sanamandra; Sum Leong; Farah Gillan Irani; Richard Hoau Gong Lo; Chow Wei Too
Journal:  Singapore Med J       Date:  2020-04-17       Impact factor: 1.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.